News

Filter

101 to 110 of 96674 results

Discussion launched about the future of biosimilars in Italy

Discussion launched about the future of biosimilars in Italy

23-10-2014

Results from a survey of 470 European physicians conducted by the Alliance for Safe Biologic Medicines…

BiosimilarBiosimilarsBiotechnologyItalyRegulation

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

23-10-2014

The recent US Food and Drug Administration approval of Harvoni (ledipasvir/sofosbuvir), Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniMarkets & MarketingPricingSovaldiUSA

EMA moves further to push Ebola treatments development

EMA moves further to push Ebola treatments development

23-10-2014

During the past months, the European Medicines Agency has put in place a system to give the best possible…

Anti-viralsEuropePharmaceuticalRegulationResearchVaccines

Mylan and Abbott amend terms of their $5.3 billion deal

Mylan and Abbott amend terms of their $5.3 billion deal

23-10-2014

US generic drugmaker Mylan and US drugmaker Abbott Laboratories have revised the pricing terms of their…

AbbottAbbott LaboratoriesGenericsMergers & AcquisitionsUSA

Cost of Australian PBS rises below rate of inflation for 2013-2014

Cost of Australian PBS rises below rate of inflation for 2013-2014

23-10-2014

The Australian Department of Health has confirmed that growth of the Pharmaceutical Benefits Scheme cost…

AustraliaMedicines AustraliaPharmaceuticalPharmaceuticals policyRegulation

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

23-10-2014

The UK’s chancellor of the exchequer, George Osborne, has announced that a partnership led by the Medical…

PharmaceuticalResearchUKUnited KingdomWELLCOME TRUST

Novartis' secukinumab achieves primary endpoints in Phase III studies for ankylosing spondylitis

Novartis' secukinumab achieves primary endpoints in Phase III studies for ankylosing spondylitis

23-10-2014

Swiss drug major Novartis says its investigational drug AIN457 (secukinumab) has achieved the primary…

Anti-Arthritics/RheumaticsNovartisPharmaceuticalResearchsecukinumabSwitzerland

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

23-10-2014

Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed…

BelgiumBiotechnologyBoardroomCardio3 BioSciencesCardio3 BioSciences

Biogen Idec third-qtr net rockets 76% but shares slump

Biogen Idec third-qtr net rockets 76% but shares slump

23-10-2014

US biotech firm Biogen Idec saw its share price plunge 7% to $303.51, after its posted third-quarter…

Biogen IdecBiotechnologyFinancialNeurologicalTecfideraUSA

101 to 110 of 96674 results

Parexel

Parexel

Back to top